Determination of hepatic galactose elimination capacity using 2-[18F]fluoro-2-deoxy-d-galactose PET/CT: reproducibility of the method and metabolic heterogeneity in a normal pig liver model-Reference-Cited by-同舟云学术

Determination of hepatic galactose elimination capacity using 2-[18F]fluoro-2-deoxy-d-galactose PET/CT: reproducibility of the method and metabolic heterogeneity in a normal pig liver model

Published:2010-08-09 Issue:1 Volume:46 Page:98-103
ISSN:0036-5521
Container-title:Scandinavian Journal of Gastroenterology
language:en
Short-container-title:Scandinavian Journal of Gastroenterology

Author:

Sørensen Michael

Publisher

Informa UK Limited

Subject

Gastroenterology

Link

http://www.tandfonline.com/doi/pdf/10.3109/00365521.2010.510574

Reference24 articles.

1. Effect of sites for blood sampling in determination of the galactose elimination capacity

2. Kinetics of Galactose Elimination.

3. Determination of the Hepatic Galactose Elimination Capacity after a Single Intravenous Injection in Man: The reproducibility and the influence of uneven distribution

4. Galactose elimination capacity as a prognostic marker in patients with severe acetaminophen-induced hepatotoxicity: 10 years? experience

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clearance tests as a diagnosis method of hepatobiliary system pathologies in animals;Agricultural Science Euro-North-East;2023-12-15

2. Application of Metabolic Reprogramming to Cancer Imaging and Diagnosis;International Journal of Molecular Sciences;2022-12-13

3. Thiamine pretreatment improves endotoxemia-related liver injury and cholestatic complications by regulating galactose metabolism and inhibiting macrophage activation;International Immunopharmacology;2022-07

4. Effect of stereotactic body radiotherapy on regional metabolic liver function investigated in patients by dynamic [18F]FDGal PET/CT;Radiation Oncology;2021-10-01

5. 2-[18F]fluoro-2-deoxy-d-galactose positron emission tomography guided functional treatment planning of stereotactic body radiotherapy of liver tumours;Physics and Imaging in Radiation Oncology;2017-01